Documents
-
- Full Text
- under embargo until 2028-03-03
-
- Download
- Title Pages_Contents
-
open access
-
- Download
- Chapter 2
-
open access
- Full text at publishers site
-
- Download
- Chapter 3
-
open access
- Full text at publishers site
-
- Download
- Chapter 4
-
open access
- Full text at publishers site
-
- Download
- Chapter 5
-
open access
- Full text at publishers site
-
- Chapter 6
- under embargo until 2028-03-03
-
- Download
- Chapter 8: Summary in English
-
open access
-
- Download
- Summary in Dutch
-
open access
-
- Download
- Propositions
-
open access
In Collections
This item can be found in the following collections:
Automated proton therapy planning: clinical validation for head-and-neck cancer and chordoma
Intensity-modulated proton therapy (IMPT) enables highly conformal radiation dose delivery while reducing radiation exposure to surrounding healthy tissues. However, treatment planning for head and neck cancer (HNC) and skull base chordomas is complex, time-consuming, and highly dependent on planner expertise. This thesis aimed to develop and clinically validate fully automated multicriterial IMPT planning using Erasmus-iCycle.
A treatment site-specific wish-list was developed and iteratively optimized for HNC. Automated IMPT plans for HNC patients showed comparable target coverage and consistently lower doses to organs at risk than clinical plans, with significantly lower predicted risks of xerostomia and dysphagia. In a blinded clinical assessment, three experienced radiation oncologists considered all automated plans clinically acceptable and preferred them over the clinical plans in the vast majority of cases. Automated planning was subsequently developed for...
Intensity-modulated proton therapy (IMPT) enables highly conformal radiation dose delivery while reducing radiation exposure to surrounding healthy tissues. However, treatment planning for head and neck cancer (HNC) and skull base chordomas is complex, time-consuming, and highly dependent on planner expertise. This thesis aimed to develop and clinically validate fully automated multicriterial IMPT planning using Erasmus-iCycle.
A treatment site-specific wish-list was developed and iteratively optimized for HNC. Automated IMPT plans for HNC patients showed comparable target coverage and consistently lower doses to organs at risk than clinical plans, with significantly lower predicted risks of xerostomia and dysphagia. In a blinded clinical assessment, three experienced radiation oncologists considered all automated plans clinically acceptable and preferred them over the clinical plans in the vast majority of cases. Automated planning was subsequently developed for challenging nasopharyngeal cancer and skull base chordoma cases. For nasopharyngeal cancer, automated planning achieved similar or improved target coverage and lower doses to critical organs, while transmission beams provided additional sparing of serial organs at risk. For skull base chordomas, automated plans generally achieved similar or improved plan quality, although patient-specific adjustments were required in some cases.
Overall, fully automated IMPT planning is clinically feasible and can improve efficiency, consistency, and plan quality for several tumor sites.
- All authors
- Huiskes, M.
- Supervisor
- Rasch, C.R.N.
- Co-supervisor
- Astreinidou, E.
- Committee
- Staring, M.; Hoogeman, M.S.; Nuyts, S.; Sonke, J.J.; Ridder, M. de
- Qualification
- Doctor (dr.)
- Awarding Institution
- Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University
- Date
- 2026-09-03
- ISBN (print)
- 9789465377186
Funding
- Sponsorship
- The work presented in this thesis was financially supported by Varian, a Siemens Healthineers Company (HollandPTC-Varian Consortium grant ID 2019021), and partly by the Surcharge for Top Consortia for Knowledge and Innovation (TKIs) from the Dutch Ministry of Economic Affairs and Climate.